These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2069560)

  • 1. Effect of schisanhenol on the antitumor activity of adriamycin.
    Lin TJ; Liu GT
    Biochem Biophys Res Commun; 1991 Jul; 178(1):207-12. PubMed ID: 2069560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection by schisanhenol against adriamycin toxicity in rat heart mitochondria.
    Lin TJ; Liu GT; Pan Y; Liu Y; Xu GZ
    Biochem Pharmacol; 1991 Oct; 42(9):1805-10. PubMed ID: 1657000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin.
    Israel M; Modest EJ; Frei E
    Cancer Res; 1975 May; 35(5):1365-8. PubMed ID: 1054622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of schisanhenol against oxygen radical induced mitochondrial toxicity on rat heart and liver.
    Lin T; Liu G; Pan Y
    Biomed Environ Sci; 1992 Mar; 5(1):57-64. PubMed ID: 1586468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection by salvianolic acid A against adriamycin toxicity on rat heart mitochondria.
    Lin TJ; Liu GT; Liu Y; Xu GZ
    Free Radic Biol Med; 1992; 12(5):347-51. PubMed ID: 1317322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of adriamycin with the DNA-adriamycin complex in chemotherapy of L1210 leukemia.
    Atassi G; Tagnon HJ
    Eur J Cancer (1965); 1974 Jul; 10(7):399-403. PubMed ID: 4457343
    [No Abstract]   [Full Text] [Related]  

  • 7. DNA--anthracycline complexes. I. Toxicity in mice and chemotherapeutic activity against L1210 leukemia of daunorubicin--DNA and adriamycin--DNA.
    Deprez-de Campeneere D; Trouet A
    Eur J Cancer (1965); 1980 Aug; 16(8):981-6. PubMed ID: 7439227
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antitumor effect of methylene blue in vivo].
    Lai BT
    Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):98-100. PubMed ID: 2806052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced effects of adriamycin by combination with a new ribonucleotide reductase inhibitor, trimidox, in murine leukemia.
    Fritzer-Szekeres M; Novotny L; Romanova D; Göbl R; Sedlak J; Vachalkova A; Rauko P; Elford HL; Szekeres T
    Life Sci; 1998; 63(7):545-52. PubMed ID: 9718080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antioxidation mechanism of schizandrin and tanshinonatic acid A and their effects on the protection of cardiotoxic action of adriamycin].
    Lin TJ
    Sheng Li Ke Xue Jin Zhan; 1991 Oct; 22(4):342-5. PubMed ID: 1796276
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental leukemia chemotherapy with a "lysosomotropic" adriamycin-DNA complex.
    Trouet A; Deprez-de Campeneere D; de Smedt-Malengreaux M; Atassi G
    Eur J Cancer (1965); 1974 Jul; 10(7):405-11. PubMed ID: 4457344
    [No Abstract]   [Full Text] [Related]  

  • 12. Potentiation of actinomycin D or adriamycin antitumor activity with DNA.
    Marks TA; Venditti JM
    Cancer Res; 1976 Feb; 36(2 Pt 1):496-504. PubMed ID: 1260747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of schisanhenol on function and surface shape of rat neutrophils.
    Zhang KJ; Lin TJ; Qin L; Liu GT
    Zhongguo Yao Li Xue Bao; 1995 May; 16(3):234-8. PubMed ID: 7660818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protective effects of schisanhenol, salvianolic acid A and SY-L on oxidative stress induced injuries of cerebral cells and their mechanisms].
    Li L
    Sheng Li Ke Xue Jin Zhan; 1998 Jan; 29(1):35-8. PubMed ID: 12501701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of N-trifuloroacetyladriamycin-14-valerate.
    Pratesi G; Casazza AM; Di Marco A
    Cancer Treat Rep; 1978 Jan; 62(1):105-10. PubMed ID: 626988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of adriamycin and ricin on L1210 leukemic cells in mice.
    Fodstad O; Pihl A
    Cancer Res; 1980 Oct; 40(10):3735-9. PubMed ID: 7438056
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae.
    Huang M; Jin J; Sun H; Liu GT
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1015-26. PubMed ID: 18270702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
    Ujiie T
    Jpn J Cancer Res; 1987 Jul; 78(7):737-47. PubMed ID: 3114200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of adriamycin toxicity by ascorbate in mice and guinea pigs.
    Fujita K; Shinpo K; Yamada K; Sato T; Niimi H; Shamoto M; Nagatsu T; Takeuchi T; Umezawa H
    Cancer Res; 1982 Jan; 42(1):309-16. PubMed ID: 7053858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of adriamycin on the reproductive integrity of cultured leukemia L1210 and P388 cells.
    Wilkott LJ; Dulmadge EA; Lloyd HH
    J Natl Cancer Inst; 1978 May; 60(5):1117-20. PubMed ID: 565414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.